
Michael Xavier Repka MD
Professor of Ophthalmology, Professor of Pediatrics, Johns Hopkins University School of Medicine; Vice Chair for Clinical Practice, Wilmer Eye Institute, Chief, Division of Pediatric Ophthalmology and Adult Strabismus
Join to view full profile
1800 Orleans StreetMaumenee LobbyBaltimore, MD 21287
Phone+1 410-955-5080
Fax+1 410-955-0809
Dr. Repka is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1980 - 1983
Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 1979 - 1980
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1979
Certifications & Licensure
MD State Medical License 1983 - 2027
PA State Medical License 1980 - 1986
NJ State Medical License 1981 - 1984
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia Start of enrollment: 1999 Apr 01
- Trial Comparing Daily Atropine Versus Weekend Atropine Start of enrollment: 2002 Jun 01
- Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia Start of enrollment: 2001 May 01
Publications & Presentations
PubMed
- Equivalent effectiveness of a prescription binocular treatment for amblyopia in real-world practice.Eric D Gaier, Brenda L Bohnsack, Maria I Bodack, Fatema Ghasia, Shelley E Hancock
Journal of Managed Care & Specialty Pharmacy. 2026-08-01 - Vision screening outcomes and follow-up intervals among socioeconomically disadvantaged students from a school-based vision program.YuQing Xu, Xinxing Guo, Kendall D Stout, David S Friedman, Michael X Repka
Ophthalmology. 2026-07-27 - Low-concentration atropine for management of myopia progression: does iris colour matter?Gareth Lingham, James Loughman, Samantha Sy Lee, Michael X Repka, Eoin Kerin
Eye. 2026-07-01
Journal Articles
- Myopia Control with Low-Dose Atropine EyedropsMichael Repka, MD, JAMA Ophthalmology
Press Mentions
New FDA-Approved Glasses Can Slow Nearsightedness in KidsDecember 1st, 2025
Digital Therapy Treatment for Amblyopia Receives FDA ClearanceOctober 12th, 2022
The Myopia GenerationSeptember 13th, 2022
Professional Memberships
- Fellow
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/michael-repka
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









